Global Diagnostic Radioisotopes Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Diagnostic Radioisotopes Market Overview

1.1 Diagnostic Radioisotopes Definition

1.2 Global Diagnostic Radioisotopes Market Size Status and Outlook (2019-2032)

1.3 Global Diagnostic Radioisotopes Market Size Comparison by Region (2019-2032)

1.4 Global Diagnostic Radioisotopes Market Size Comparison by Type (2019-2032)

1.5 Global Diagnostic Radioisotopes Market Size Comparison by Application (2019-2032)

1.6 Global Diagnostic Radioisotopes Market Size Comparison by Sales Channel (2019-2032)

1.7 Diagnostic Radioisotopes Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Diagnostic Radioisotopes Market Snapshot

2.2 Global Diagnostic Radioisotopes Market Volume & Revenue (2019-2025)

2.3 Global Diagnostic Radioisotopes Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Diagnostic Radioisotopes Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Diagnostic Radioisotopes Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Diagnostic Radioisotopes Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Diagnostic Radioisotopes Market Segment Analysis by Player

3.1 Global Diagnostic Radioisotopes Sales and Market Share by Player (2023-2025)

3.2 Global Diagnostic Radioisotopes Revenue and Market Share by Player (2023-2025)

3.3 Global Diagnostic Radioisotopes Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Diagnostic Radioisotopes Market Segment Analysis by Type

4.1 Global Diagnostic Radioisotopes Market by Type

4.1.1 Tc-99m

4.1.2 F-18

4.1.3 Others

4.2 Global Diagnostic Radioisotopes Sales and Market Share by Type (2019-2025)

4.3 Global Diagnostic Radioisotopes Revenue and Market Share by Type (2019-2025)

4.4 Global Diagnostic Radioisotopes Average Price by Type (2019-2025)

4.5 Leading Players of Diagnostic Radioisotopes by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Diagnostic Radioisotopes Market Segment Analysis by Application

5.1 Global Diagnostic Radioisotopes Market by Application

5.1.1 Oncology

5.1.2 Cardiology

5.1.3 Others

5.2 Global Diagnostic Radioisotopes Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Diagnostic Radioisotopes by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Diagnostic Radioisotopes Market Segment Analysis by Sales Channel

6.1 Global Diagnostic Radioisotopes Market by Sales Channel

6.1.1 Global Diagnostic Radioisotopes Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Diagnostic Radioisotopes Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Diagnostic Radioisotopes Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Diagnostic Radioisotopes by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Diagnostic Radioisotopes Market Segment Analysis by Region

7.1 Global Diagnostic Radioisotopes Market Size and CAGR by Region (2019-2032)

7.2 Global Diagnostic Radioisotopes Sales and Market Share by Region (2019-2025)

7.3 Global Diagnostic Radioisotopes Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Diagnostic Radioisotopes Market Share by Type

7.4.3 North America Diagnostic Radioisotopes Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Diagnostic Radioisotopes Market Share by Type

7.5.3 Europe Diagnostic Radioisotopes Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Diagnostic Radioisotopes Market Share by Type

7.6.3 Asia-Pacific Diagnostic Radioisotopes Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Diagnostic Radioisotopes Market Share by Type

7.7.3 South America Diagnostic Radioisotopes Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Diagnostic Radioisotopes Market Share by Type

7.8.3 Middle East & Africa Diagnostic Radioisotopes Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Diagnostic Radioisotopes Players

8.1 Bracco Imaging

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Bayer

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Curium Pharmaceuticals

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Nordion

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Triad Isotopes

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Lantheus

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 GE Healthcare

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 China Isotope & Radiation

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Jubilant Pharma

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Eli Lilly

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Novartis

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 SIEMENS

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Dongcheng

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Navidea

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Others

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Diagnostic Radioisotopes

9.1 Industrial Chain of Diagnostic Radioisotopes

9.2 Upstream of Diagnostic Radioisotopes

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Diagnostic Radioisotopes

9.3.1 Leading Distributors/Dealers of Diagnostic Radioisotopes

9.3.2 Leading Consumers of Diagnostic Radioisotopes

Chapter 10. Global Diagnostic Radioisotopes Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Diagnostic Radioisotopes Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Diagnostic Radioisotopes Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Diagnostic Radioisotopes (2026-2032)

11.1 Global Diagnostic Radioisotopes Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Diagnostic Radioisotopes Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Diagnostic Radioisotopes Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Diagnostic Radioisotopes Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Diagnostic Radioisotopes Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Diagnostic Radioisotopes Import-Export (2019-2025)

12.2 Europe Diagnostic Radioisotopes Import-Export (2019-2025)

12.3 Asia Pacific Diagnostic Radioisotopes Import-Export (2019-2025)

12.4 South America Diagnostic Radioisotopes Import-Export (2019-2025)

12.5 Middle East & Africa Diagnostic Radioisotopes Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Diagnostic Radioisotopes Demand-Supply (2019-2025)

13.2 Europe Diagnostic Radioisotopes Demand-Supply (2019-2025)

13.3 Asia Pacific Diagnostic Radioisotopes Demand-Supply (2019-2025)

13.4 South America Diagnostic Radioisotopes Demand-Supply (2019-2025)

13.5 Middle East & Africa Diagnostic Radioisotopes Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources